Showing results (141-150 of 263) with videos related to
Sort By:
Pageof 27
Epilepsy Research|July 1, 1995
Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizuresE Ben-Menachem, B Söderfelt, A Hamberger, et al.Cell and Tissue Research|November 23, 2014
Deregulated proliferation and differentiation in brain tumorsFredrik J Swartling, Matko Čančer, Aaron Frantz, et al.International Journal of Cancer|January 17, 1997
Breast cancer risk associated with gynecologic surgery and indications for such surgeryC Schairer, I Persson, M Falkeborn, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 allelesE Aklillu, I Persson, L Bertilsson, et al.Mutation Research|December 1, 1995
The aetiology and pathogenesis of human breast cancerH O Adami, I Persson, A Ekbom, et al.Archives of Internal Medicine|May 24, 1993
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in SwedenM Falkeborn, I Persson, A Terént, et al.Cancer Causes & Control : CCC|July 6, 2000
Breast cancer risk and lifetime leisure-time and occupational physical activity (Sweden)T Moradi, O Nyrén, M Zack, et al.Carcinogenesis|April 7, 2000
Estrogen receptor alpha gene polymorphisms and endometrial cancer riskE Weiderpass, I Persson, H Melhus, et al.Life Sciences|September 6, 2000
Astrocyte beta1-adrenergic receptor immunoreactivity and agonist induced increases in [Ca2+]i: differential results indicative of a modified membrane receptorT Thorlin, P Anders, I Persson, et al.Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1983
Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part II Persson, H O Adami, B S Lindberg, et al.Pageof 27